MarketPR
Vaso Corporation shares have climbed 149% over the past year, significantly outpacing the S&P 500's 17.2% gain and the industry's 8.9% increase.
The Plainview, New York-based company attributes this performance to stronger results in its professional sales services and proprietary medical products segments, alongside the completion of its exit from network and IT services.
In the second quarter of 2026, Vaso reported higher revenues and improved profitability driven by increased business activity across its healthcare operations.
Management noted that operating efficiency improved following the divestiture of its healthcare IT business.
Keep reading